Management of severe infections by multi-resistant Gram-negative bacteria in critically ill patients

Area of Science:

• Infectious Diseases
• Critical Care Medicine
• Microbiology

Background:

• Multi-resistant Gram-negative bacilli (MDR-GNB) infections represent a significant global public health concern.
• Mechanisms of resistance include altered permeability, efflux pumps, and inactivating enzymes like β-lactamases and carbapenemases.
• Traditional therapies are often ineffective against MDR-GNB due to widespread resistance.

Purpose of the Study:

• To review and update the diagnosis and treatment strategies for MDR-GNB infections in critically ill patients.
• To guide the appropriate use of new broad-spectrum antibiotics for both empirical and targeted therapy.
• To highlight the importance of infection control measures in managing MDR-GNB.

Main Methods:

• Literature review focusing on recent advancements in MDR-GNB diagnosis and treatment.
• Analysis of the role of new broad-spectrum antibiotics since 2015.
• Emphasis on practical clinical application for critically ill patients.

Main Results:

• New broad-spectrum antibiotics have become available since 2015, offering improved treatment options.
• Effective management requires a combination of appropriate antibiotic selection and robust infection control.
• Updated diagnostic and therapeutic guidelines are crucial for combating MDR-GNB.

Conclusions:

• The emergence of new antibiotics has transformed the treatment landscape for MDR-GNB infections.
• A comprehensive approach integrating diagnostics, novel therapeutics, and infection control is essential.
• This review provides a practical framework for clinicians managing critically ill patients with MDR-GNB infections.